Showing results (1971-1980 of 2,232) with videos related to
Sort By:
Pageof 224
BMC Health Services Research|June 3, 2021
Protocol for a two-arm pragmatic stepped-wedge hybrid effectiveness-implementation trial evaluating Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship (ENCOMPASS)Marc Kowalkowski, Tara Eaton, Andrew McWilliams, et al.The Journal of Infectious Diseases|February 3, 2021
Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody ResponsesBenjamin H L Harris, Mohamed Zuhair, Matteo Di Giovannantonio, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 5, 2025
Shared decision making in routine oncology appointments with Black patients with lung cancerKatarina E AuBuchon, Amanda Khoudary, Jennifer D Rodriguez, et al.Briefings in Bioinformatics|May 20, 2021
Utilizing graph machine learning within drug discovery and developmentThomas Gaudelet, Ben Day, Arian R Jamasb, et al.Gynecologic Oncology|February 27, 2007
A multi-institutional review of outcomes of endometrial stromal sarcomaCharles A Leath, Warner K Huh, Johnny Hyde, et al.Physical Review Letters|September 26, 2012
Impact of small-angle scattering on ballistic transport in quantum dotsA M See, I Pilgrim, B C Scannell, et al.Arthritis and Rheumatism|March 24, 1999
Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosusD J Griffiths, S P Cooke, C Hervé, et al.Neurogenetics|September 21, 2005
Lrrk2 pathogenic substitutions in Parkinson's diseaseIgnacio F Mata, Jennifer M Kachergus, Julie P Taylor, et al.Kidney International|June 17, 2020
Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndromeYuzhou Zhang, Robin A Kremsdorf, C John Sperati, et al.BMJ Open|January 29, 2016
Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall interventionN Bayman, D Ardron, L Ashcroft, et al.Pageof 224